A Master Protocol study to investigate biomarker-guided novel anticancer agent(s) as monotherapy or combination therapy in participants with advanced/recurrent ovarian cancer

Trial Identifier:	D9724C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	September 2025
Primary Completion Date:	December 2025
Study Completion Date:	December 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
ES	Barcelona, ES, 08028

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.